http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105030681-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 |
filingDate | 2015-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105030681-B |
titleOfInvention | A kind of liposome medicament and preparation method thereof |
abstract | The invention discloses a kind of liposome medicament and preparation method thereof.Present invention treatment brain tumor has the liposome medicament of double-active ingredient, its active ingredient contains liposoluble active medicine by target liposomes and water-soluble active drug forms;The target liposomes are modified for amino on the surface of liposome by 4 aminobenzene α D mannopyranoses glycosides.The target liposomes contain water-soluble active drug and form a kind of drug-loaded liposome for treating brain tumor.The present invention prepares treatment brain tumor medicine using the drug-loaded liposome precursor after modification or target liposomes, has the function of to target blood-brain barrier, and can pass through the ability and then lesions position of blood-brain barrier;The present invention contains curcumin and quinacrine in target liposomes, and two medicines are shared while antitumor action is improved, and strengthen its apoptosis-promoting effect to tumour cell and its stem cell. |
priorityDate | 2015-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.